Education and Health Notices




NEW ZEALAND GAZETTE, No. 140 — 20 NOVEMBER 2014

The guidelines are available, free of charge, from the Local Government Commission, PO Box 5362, Wellington, or may be downloaded from the Commission’s website

www.lgc.govt.nz

or may be inspected at the Commission’s offices at Level 10, 46 Waring Taylor Street, Wellington.

DONALD RIEZEBOS, Principal Advisor, Local Government Commission.

2014-go7073

Notice of Dissolution of Isla Bank School (3969) Board of Trustees and Appointment of a Commissioner

Pursuant to section 78N(3)(b) of the Education Act 1989, as the Secretary for Education’s delegate, I hereby dissolve the board of trustees of Isla Bank School and appoint

Paul Ferris

as commissioner to replace that board.

This notice takes effect on the day of publication.

Dated at Wellington this 12th day of November 2014.

JIM GREENING, Group Manager, Schools and Student Support, Sector Enablement and Support, Ministry of Education.

2014-go7008

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Aciclovir-Claris

Active Ingredient:
Aciclovir 25mg/mL

Dosage Form:
Solution for infusion

New Zealand Sponsor:
AFT Pharmaceuticals Limited

Manufacturer:
Claris Life Sciences Limited, Gujarat, India

Product:
Cefuroxime Actavis

Active Ingredient:
Cefuroxime sodium 789mg equivalent to Cefuroxime 750mg

Dosage Form:
Powder for injection

New Zealand Sponsor:
Actavis New Zealand Limited

Manufacturer:
Facta Farmaceutica SpA, Teramo, Italy

Product:
Cefuroxime Actavis

Active Ingredient:
Cefuroxime sodium 1578mg equivalent to Cefuroxime 1500mg

Dosage Form:
Powder for injection

New Zealand Sponsor:
Actavis New Zealand Limited

Manufacturer:
Facta Farmaceutica SpA, Teramo, Italy

Product:
Clonidine Transdermal System, USP

Active Ingredient:
Clonidine 2.52mg equivalent to 0.1mg/24hr

Dosage Form:
Transdermal patch

New Zealand Sponsor:
Mylan New Zealand Limited

Manufacturer:
Mylan Technologies, Vermont, United States of America

Product:
Clonidine Transdermal System, USP

Active Ingredient:
Clonidine 5.04mg equivalent to 0.2mg/24hr

Dosage Form:
Transdermal patch

New Zealand Sponsor:
Mylan New Zealand Limited

Manufacturer:
Mylan Technologies, Vermont, United States of America

144



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 140





✨ LLM interpretation of page content

🏘️ Guidelines for Local Authority Representation Reviews

🏘️ Provincial & Local Government
Local Government Commission, Representation Reviews, Guidelines
  • Donald Riezebos, Principal Advisor, Local Government Commission

🎓 Dissolution of Isla Bank School Board of Trustees and Appointment of Commissioner

🎓 Education, Culture & Science
12 November 2014
School Board, Dissolution, Commissioner Appointment, Isla Bank School
  • Paul Ferris, Appointed Commissioner

  • Jim Greening, Group Manager, Schools and Student Support, Sector Enablement and Support, Ministry of Education

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
Medicines, Consent, Distribution, Medicines Act 1981
  • Minister of Health